Description

The global veterinary medicine market is poised to grow by US$ 9.1 billion from 2022 to 2028, registering a CAGR of 4.8% during the forecast period, according to StrategyHelix.

The report provides up-to-date market size data for period 2018-2021 and forecast to 2028 covering key market aspects like sales value for veterinary medicine. The global veterinary medicine market is segmented on the basis of product, route of administration, animal type, distribution channel, and region. By product, the global veterinary medicine market has been segmented into drugs, medicated feed additives, vaccines. Based upon route of administration, the global veterinary medicine market is categorized into oral (powder, tablets), parenteral, others (topical, carrier). On the basis of animal type, the global veterinary medicine market has been segmented into companion animals, livestock animals. By distribution channel, the global veterinary medicine market has been segmented into pharmacies & drugs stores, veterinary hospitals & clinics. In terms of geography, the global veterinary medicine market has been segmented into North America, Asia Pacific, Europe, Rest of the World (ROW).

The vaccine market is further segmented into DNA vaccines, inactivated vaccines, live attenuated vaccines, recombinant vaccines, subunit vaccines, toxoids, and others. Furthermore, the drug market has been categorized into analgesics, anti-infectives, anti-inflammatory, parasiticides, and others. The livestock animal market is further divided into cattle, fish, poultry, sheep & goats, and swine. The companion animal market is further segmented into cats, dogs, horses, and others.

The global veterinary medicine market is highly competitive. As of 2021, the major players in the global veterinary medicine market were ADM Animal Nutrition Inc., Bayer AG, Biogenesis Bago S.A., Boehringer Ingelheim International GmbH, Ceva Animal Health LLC, Chanelle Pharma Unlimited, Dechra Pharmaceuticals PLC, Elanco Animal Health Incorporated, Evonik Industries AG, Huvepharma EOOD, Krka d. d., Merck & Co. Inc., Norbrook Laboratories Ltd., Nutreco N.V., Orion Corporation, Ourofino Saude Animal, PAHC Phibro Animal Health Corporation, Vetoquinol SA, Virbac Corporation, Zoetis Inc.

The report is an invaluable resource for companies and organizations active in this industry. It provides a cohesive picture of the veterinary medicine market to help drive informed decision making for industry executives, policy makers, academic, and analysts.

Report Scope

Product: drugs, medicated feed additives, vaccines
Route of administration: oral (powder, tablets), parenteral, others (topical, carrier)
Animal type: companion animals, livestock animals
Distribution channel: pharmacies & drugs stores, veterinary hospitals & clinics
Region: North America, Asia Pacific, Europe, Rest of the World (ROW)
Years considered: this report covers the period 2018 to 2028

Key Benefits for Stakeholders

– Get a comprehensive picture of the global veterinary medicine market
– Pinpoint growth sectors and trends for investment

Table of Contents

Part 1. Introduction
– Scope of the study
– Study period
– Geographical scope
– Research methodology
Part 2. Veterinary medicine market overview
Part 3. Market breakdown by product
– Drugs
– Medicated feed additives
– Vaccines
Part 4. Market breakdown by route of administration
– Oral (powder, tablets)
– Parenteral
– Others (topical, carrier)
Part 5. Market breakdown by animal type
– Companion animals
– Livestock animals
Part 6. Market breakdown by distribution channel
– Pharmacies & drugs stores
– Veterinary hospitals & clinics
Part 7. Market breakdown by region
– North America
– Asia Pacific
– Europe
– Rest of the World (ROW)
Part 8. Key companies
– ADM Animal Nutrition, Inc.
– Bayer AG
– Biogenesis Bago S.A.
– Boehringer Ingelheim International GmbH
– Ceva Animal Health, LLC
– Chanelle Pharma Unlimited
– Dechra Pharmaceuticals PLC
– Elanco Animal Health Incorporated
– Evonik Industries AG
– Huvepharma EOOD
– Krka, d. d.
– Merck & Co., Inc.
– Norbrook Laboratories Ltd.
– Nutreco N.V.
– Orion Corporation
– Ourofino Saude Animal
– PAHC Phibro Animal Health Corporation
– Vetoquinol SA
– Virbac Corporation
– Zoetis Inc.
About StrategyHelix
Disclaimer